Temporary Right-Ventricular Assist Devices: A Systematic Review.
dc.contributor.author | Abdelshafy, Mahmoud | |
dc.contributor.author | Caliskan, Kadir | |
dc.contributor.author | Guven, Goksel | |
dc.contributor.author | Elkoumy, Ahmed | |
dc.contributor.author | Elsherbini, Hagar | |
dc.contributor.author | Elzomor, Hesham | |
dc.contributor.author | Tenekecioglu, Erhan | |
dc.contributor.author | Akin, Sakir | |
dc.contributor.author | Soliman, Osama | |
dc.date.accessioned | 2024-10-02T11:30:56Z | |
dc.date.available | 2024-10-02T11:30:56Z | |
dc.date.issued | 2022-01-26 | |
dc.identifier.issn | 2077-0383 | |
dc.identifier.pmid | 35160064 | |
dc.identifier.doi | 10.3390/jcm11030613 | |
dc.identifier.uri | http://hdl.handle.net/10147/643006 | |
dc.description | Acute right-sided heart failure (RHF) is a complex clinical syndrome, with a wide range of clinical presentations, associated with increased mortality and morbidity, but about which there is a scarcity of evidence-based literature. A temporary right-ventricular assist device (t-RVAD) is a potential treatment option for selected patients with severe right-ventricular dysfunction as a bridge-to-recovery or as a permanent solution. We sought to conduct a systematic review to determine the safety and efficacy of t-RVAD implantation. Thirty-one studies met the inclusion criteria, from which data were extracted. Successful t-RVAD weaning ranged between 23% and 100%. Moreover, 30-day survival post-temporary RAVD implantation ranged from 46% to 100%. Bleeding, acute kidney injury, stroke, and device malfunction were the most commonly reported complications. Notwithstanding this, t-RVAD is a lifesaving option for patients with severe RHF, but the evidence stems from small non-randomized heterogeneous studies utilizing a variety of devices. Both the etiology of RHF and time of intervention might play a major role in determining the t-RVAD outcome. Standardized endpoints definitions, design and methodology for t-RVAD trials is needed. Furthermore, efforts should continue in improving the technology as well as improving the timely provision of a t-RVAD. | en_US |
dc.language.iso | en | en_US |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Efficacy | en_US |
dc.subject | right-sided heart failure | en_US |
dc.subject | Safety | en_US |
dc.subject | systematic review | en_US |
dc.subject | temporary right ventricular assist device | en_US |
dc.title | Temporary Right-Ventricular Assist Devices: A Systematic Review. | en_US |
dc.type | Article | en_US |
dc.identifier.journal | Journal of clinical medicine | en_US |
dc.source.journaltitle | Journal of clinical medicine | |
dc.source.volume | 11 | |
dc.source.issue | 3 | |
refterms.dateFOA | 2024-10-02T11:30:57Z | |
dc.source.country | Switzerland |